David Leys
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 34
- Biochemistry top 0.5%
- Biotechnology top 0.5%
- Biochemical and biochemical processes 27
- Molecular Biology top 1%
- Microbial Metabolic Engineering and Bioproduction 28
- Porphyrin Metabolism and Disorders 25
- Enzyme Catalysis and Immobilization 24
- Photosynthetic Processes and Mechanisms 24
- Inorganic Chemistry top 1%
-
- Enzyme Structure and Function 27
-
- Tuberculosis Research and Epidemiology 20
David Leys
186 papers receiving 8.6k citations
Peers
Comparison fields: 5 of 148
- Pharmacology 1.6k
- Biochemistry 704
- Biotechnology 714
- Molecular Biology 5.6k
- Inorganic Chemistry 1.0k
Countries citing papers authored by David Leys
This map shows the geographic impact of David Leys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Leys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Leys more than expected).
Fields of papers citing papers by David Leys
This network shows the impact of papers produced by David Leys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Leys. The network helps show where David Leys may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Leys, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2022 | 16 | |
| 5 | 2022 | 5 | |
| 6 | 2019 | 44 | |
| 7 | 2018 | 136 | |
| 8 | 2017 | 6 | |
| 9 | 2017 | 28 | |
| 10 | 2017 | 64 | |
| 11 | 2017 | 81 | |
| 12 | 2015 | 97 | |
| 13 | Research article: The transcriptional regulator CprK detects chlorination by combining direct and indirect readout mechanisms | 2013 | 94 |
| 14 | 2011 | 17 | |
| 15 | 2010 | 131 | |
| 16 | 2010 | 42 | |
| 17 | 2008 | 39 | |
| 18 | 2008 | 107 | |
| 19 | P450 systems in Mycobacterium tuberculosis: structure, function and drug targeting | 2007 | 1 |
| 20 | 2006 | 27 |
About David Leys
David Leys is a scholar working on Biochemistry, Pharmacology and Biotechnology, having authored 190 papers that have together received 8.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (34 papers), Microbial Metabolic Engineering and Bioproduction (28 papers), Enzyme Structure and Function (27 papers), Biochemical and biochemical processes (27 papers), Porphyrin Metabolism and Disorders (25 papers), Enzyme Catalysis and Immobilization (24 papers), Photosynthetic Processes and Mechanisms (24 papers) and Tuberculosis Research and Epidemiology (20 papers). The work is most often cited by research in Pharmacology (1.6k citations), Biochemistry (704 citations) and Biotechnology (714 citations). David Leys has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Nigel S. Scrutton, Andrew W. Munro, Colin Levy, Kirsty J. McLean, Mark S. Dunstan, Karl Fisher, K.A.P. Payne, Stephen E. J. Rigby, Helen S. Toogood and Sam Hay. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, FEBS Journal, Nature and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.